This title appears in the Scientific Report :
2019
Please use the identifier:
http://dx.doi.org/10.1055/a-0807-8137 in citations.
SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM)
SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM)
The aim of the S1 guideline is to assist in establishing the indication and in performing, interpreting and reporting SPECT investigations of the dopamine transporter (DAT) with DaTSCANTM. Compared to the preceding version dated from 2007 the current update considers relevant new publications, the g...
Saved in:
Personal Name(s): | Tatsch, Klaus (Corresponding author) |
---|---|
Buchert, Ralph / Bartenstein, Peter / Barthel, Henryk / Boecker, Henning / Brust, Peter / Drzezga, Alexander / la Fougère, Christian / Gründer, Gerhard / Grünwald, Frank / Krause, Bernd-J. / Kuwert, Torsten / Langen, Karl-Josef / Rominger, Axel / Sabri, Osama / Schreckenberger, Mathias / Meyer, Philipp T. | |
Contributing Institute: |
Molekulare Organisation des Gehirns; INM-2 Physik der Medizinischen Bildgebung; INM-4 |
Published in: | Nuklearmedizin, 58 (2019) 01, S. 5 - 16 |
Imprint: |
Stuttgart
Thieme
2019
|
PubMed ID: |
30769368 |
DOI: |
10.1055/a-0807-8137 |
Document Type: |
Journal Article |
Research Program: |
Neuroimaging |
Publikationsportal JuSER |
The aim of the S1 guideline is to assist in establishing the indication and in performing, interpreting and reporting SPECT investigations of the dopamine transporter (DAT) with DaTSCANTM. Compared to the preceding version dated from 2007 the current update considers relevant new publications, the guidelines of the European (EANM) and Society of Nuclear Medicine (SNM), and the current version of the S3 guideline of the German Society of Neurology on „Idiopathic Parkinsonsian Syndrome“. In addition new technical developments are incorporated. |